Withdrawn before it began
Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer
NCT02252393 · Case Comprehensive Cancer Center · Updated 9 Nov 2016
- What is being tested
- robot-assisted laparoscopic surgery; robot-assisted laparoscopic surgery; intraoperative complication management/prevention; intraoperative complication management/prevention; quality-of-life assessment
- For
- Recurrent Bladder Cancer; Stage 0 Bladder Cancer; Stage I Bladder Cancer; Stage II Bladder Cancer; Urinary Complications
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages Not stated. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started Oct 2015, ends Nov 2016. Registered 30 Sept 2014.
- Results
- None posted yet.
In the researchers' words
This randomized clinical trial studies intracorporeal or extracorporeal urinary diversion during robotic assisted radical cystectomy in reducing complications in patients with bladder cancer. Radical cystectomy is surgery to remove the entire bladder as well as nearby tissues and organs. After the bladder is removed, urinary diversion (a surgical procedure to make a new way for urine to leave the body) is performed. It is not yet known whether intracorporeal (within the body) or extracorporeal (outside of the body) urinary diversion is a better method in patients with bladder cancer undergoing robotic assisted radical cystectomy.